Long-Term Monitoring of Individuals With Chronic Obstructive Pulmonary Disease Using Digital Health Technology: Qualitative Study

被引:0
|
作者
Chien, Shih-Ying [1 ,2 ,3 ]
Hu, Han-Chung [4 ,5 ]
Cho, Hsiu-Ying [5 ]
机构
[1] Chang Gung Univ, Dept Ind Design, 259,Wen Hwa 1st Rd, Taoyuan 333, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Publ Hlth & Med Humanities, Hsinchu, Taiwan
[3] Linkou Chang Gung Mem Hosp CGMH, Dept Phys Med & Rehabil, Taoyuan, Taiwan
[4] Linkou Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan
[5] Linkou Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan
关键词
digital health; chronic obstructive pulmonary disease; digital health technology; barriers and facilitators; Taiwan; OF-LIFE; REHABILITATION; HOSPITALIZATION; HYPERINFLATION; INTERVENTIONS; EXACERBATION; BARRIERS; OUTCOMES; DYSPNEA;
D O I
10.2196/63660
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Digital health adoption in clinical practice has been widespread, yet there remains further potential for optimizing care specifically for chronic obstructive pulmonary disease (COPD). This study therefore conducted qualitative research involving 35 health care professionals from a range of hospitals in Taiwan. Objective: This study aims to investigate barriers and facilitators related to the implementation of digital health technology (DHT) in the long-term monitoring of individuals with COPD based on clinical experiences in Taiwan. The perspectives of Taiwanese health care professionals provided valuable insights into the challenges and opportunities associated with using DHT for the management and enhancement of respiratory rehabilitation and long-term monitoring of patients with COPD. Methods: Several key themes related to the development of DHT were identified. Barriers encompassed concerns pertaining to digital safety, insurance coverage, constraints related to medical resources, and the presence of a digital divide. Facilitators included the potential for cost reduction, personalized prescriptions, and instilling motivation in users. Results: To enhance the acceptance and use of DHT, embracing a user-centered approach that prioritizes the distinct needs of all parties involved is recommended. Moreover, optimizing and leveraging the effective use of DHT in managing the health of individuals with COPD promises to deliver care characterized by greater precision and efficiency. Conclusions: Overall, the benefits of using DHT for the long-term care of patients with COPD outweigh the disadvantages. After the COVID-19 pandemic, there has been an increased emphasis in Taiwan on the effectiveness of DHT in managing chronic diseases. Relevant studies including this paper have suggested that web-based exercise management systems could benefit patients with COPD in rehabilitation and tracking. Our findings provide meaningful directions for future research endeavors and practical implementation. By addressing identified barriers and capitalizing on facilitators, advancements can be made in the development and use of DHT, especially in overcoming challenges such as information security and operational methods. The implementation of the recommended strategies will likely lead to improved COPD care outcomes.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease
    Hansen, Gorm Mork
    Marott, Jacob Louis
    Holtermann, Andreas
    Gyntelberg, Finn
    Lange, Peter
    Jensen, Magnus T.
    THORAX, 2019, 74 (09) : 843 - 848
  • [32] Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment
    Gulbas, G.
    Gunen, H.
    In, E.
    Kilic, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (02) : 152 - 157
  • [33] Physical fitness and the long-term risk of incident chronic obstructive pulmonary disease
    Hansen, G. M.
    Holtermann, A.
    Gyntelberg, F.
    Jensen, M. T.
    EUROPEAN HEART JOURNAL, 2018, 39 : 909 - 909
  • [34] Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease
    Tanaka, Kyuto
    Kamiishi, Nobufumi
    Miyata, Jun
    Kabata, Hiroki
    Masaki, Katsunori
    Ogura-Tomomatsu, Hiromi
    Tomomatsu, Katsuyoshi
    Suzuki, Yusuke
    Fukunaga, Koichi
    Sayama, Koichi
    Betsuyaku, Tomoko
    Asano, Koichiro
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 12 (03) : 233 - 239
  • [35] Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease
    Gauthier, Amelie
    Bernard, Sarah
    Bernard, Emmanuelle
    Simard, Serge
    Maltais, Francois
    Lacasse, Yves
    CHRONIC RESPIRATORY DISEASE, 2018, 16
  • [36] Long-Term Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease with Sarcopenia
    Choi, Yong Jun
    Kim, Taehee
    Park, Hye Jung
    Cho, Jae Hwa
    Byun, Min Kwang
    LIFE-BASEL, 2023, 13 (08):
  • [37] LONG-TERM EFFECTS OF PROTRIPTYLINE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    SERIES, F
    MARC, I
    CORMIER, Y
    LAFORGE, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (06): : 1487 - 1490
  • [38] Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients
    Eroglu, Selma Aydogan
    Gunen, Hakan
    Yakar, Halil Ibrahim
    Yildiz, Ethem
    Kavas, Murat
    Duman, Dildar
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1379 - 1386
  • [39] Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
    Blasi, Francesco
    Bonardi, Daniela
    Aliberti, Stefano
    Tarsia, Paolo
    Confalonieri, Marco
    Amir, Omar
    Carone, Mauro
    Di Marco, Fabiano
    Centanni, Stefano
    Guffanti, Enrico
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (03) : 200 - 207
  • [40] Inhaled Corticosteroids in the Long-Term Management of Patients with Chronic Obstructive Pulmonary Disease
    Don D. Sin
    S. F. Paul Man
    Drugs & Aging, 2003, 20 : 867 - 880